chemokine receptor
Showing 1 - 25 of 7,471
Thymoma Trial in Beijing (68Ga-Pentixafor)
Recruiting
- Thymoma
-
Beijing, Beijing, ChinaPeking Union Medical College Hospitall, Chinese Academy of Medic
Oct 11, 2023
COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)
Recruiting
- COVID-19
- SARS-CoV2 Infection
- Candesartan Cilexetil
- +3 more
-
Guntur, India
- +4 more
Mar 13, 2022
Aldosterone-Producing Adenoma Trial in Chengdu ([18F]AlF-NOTA-pentixather PET/CT)
Recruiting
- Aldosterone-Producing Adenoma
- [18F]AlF-NOTA-pentixather PET/CT
-
Chengdu, Sichuan, ChinaSichuan Academy of Medical Sciences.Sichuan Provincial People's
Apr 3, 2023
Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)
Active, not recruiting
- Triple -Negative Breast Cancer
- +4 more
- Biopsy
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Aug 1, 2022
Lymphoma, Multiple Myeloma, Leukemia Trial in Fuzhou (68Ga-Pentixafor)
Recruiting
- Lymphoma
- +2 more
-
Fuzhou, Fujian, ChinaDepartment of Nuclear Medicine, First Affiliated Hospital of Fuj
Apr 6, 2021
Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,
Active, not recruiting
- Folliculotropic Mycosis Fungoides
- +7 more
- Extracorporeal Photopheresis
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Atlanta (procedure, biological,
Recruiting
- Mycosis Fungoides
- +2 more
- Extracorporeal Photopheresis
- +2 more
-
Atlanta, GeorgiaEmory University Hospital
Jun 15, 2022
Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell
Recruiting
- Recurrent Adult T-Cell Leukemia/Lymphoma
- +3 more
- Cyclophosphamide
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 18, 2022
Recurrent DLBCL, Recurrent High Grade B-Cell Lymphoma, Recurrent Transformed B-Cell Non-Hodgkin Lymphoma Trial in United States
Active, not recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- +5 more
- Mogamulizumab
- Pembrolizumab
-
Sacramento, California
- +7 more
Sep 15, 2022
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in
Suspended
- Anatomic Stage 0 Breast Cancer AJCC v8
- +18 more
- Celecoxib
- +6 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 4, 2022
Mycosis Fungoides, Recurrent Mycosis Fungoides, Recurrent Mycosis Fungoides and Sezary Syndrome Trial in United States
Recruiting
- Mycosis Fungoides
- +11 more
- Biospecimen Collection
- +5 more
-
Duarte, California
- +12 more
Jan 7, 2023
Multiple Myeloma, Lymphoma Trial in Beijing (68Ga-Pentixafor)
Unknown status
- Multiple Myeloma
- Lymphoma
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Dec 26, 2019
Venous Ulcer, Sickle Cell Ulcer, Diabetic Ulcer Trial in Paris (Saliva sampling, Blood sampling, Interviews)
Not yet recruiting
- Venous Ulcer
- +3 more
- Saliva sampling
- +3 more
-
Paris, Ile De France, FranceDermatology unit - Cochin Hospital - APHP
Sep 8, 2023
Hiv, Kidney Transplant, HIV Reservoir Trial in Baltimore (Sirolimus + Maraviroc)
Withdrawn
- Hiv
- +3 more
- Sirolimus + Maraviroc
-
Baltimore, MarylandInstitute of human virology
Dec 12, 2019
CXCR4, PET/CT, Hematological Malignancy Trial in Wuhan (68Ga-pentixafor, PET/CT)
Not yet recruiting
- CXCR4
- +2 more
- 68Ga-pentixafor
- PET/CT
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Feb 15, 2022
Multiple Myeloma Trial in Beijing (68Ga-Pentixather, 68Ga-Pentixafor)
Recruiting
- Multiple Myeloma
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 3, 2022
Healthy Pediatric Inflammatory Response to Vaccination.
Enrolling by invitation
- Healthy Controls
- Blood Collection
-
Rochester, MinnesotaMayo Clinic
Feb 9, 2022
Immune System, Nutrition, Inflammation Trial in Davis (High saturated fat challenge meal, High mono unsaturated fat challenge
Not yet recruiting
- Immune System
- +2 more
- High saturated fat challenge meal
- High mono unsaturated fat challenge meal
-
Davis, CaliforniaUSDA Western Human Nutrition Research Center
Mar 29, 2023
Idiopathic CD4-Positive, T-Lymphocytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
- Idiopathic CD4-Positive
- T-Lymphocytopenia
- Filgrastim
- Plerixafor
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023